ASO Visual Abstract: Overuse of Axillary Surgery for Patients With Ductal Carcinoma In Situ: Opportunity for De-Escalation Mara A. PiltinTanya L. HoskinJudy C. Boughey ASO Visual Abstract 25 July 2022 Pages: 7715 - 7715
Does Residual Cancer Burden Predict Local Recurrence After Neoadjuvant Chemotherapy? Christine V. PestanaChad A. LivasyRichard L. White Jr Breast Oncology 09 July 2022 Pages: 7716 - 7724
ASO Visual Abstract: Does Residual Cancer Burden Predict Local Recurrence after Neoadjuvant Chemotherapy? Christine V. PestanaChad A LivasyRichard L. White Jr. ASO Visual Abstract 13 September 2022 Pages: 7725 - 7725
Impact of the Histologic Pattern of Residual Tumor After Neoadjuvant Chemotherapy on Recurrence and Survival in Stage I–III Breast Cancer Alison LawsRicardo PastorelloTari King Breast Oncology 09 July 2022 Pages: 7726 - 7736
ASO Visual Abstract: Impact of the Histologic Pattern of Residual Tumor After Neoadjuvant Chemotherapy on Recurrence and Survival in Stage I–III Breast Cancer Alison LawsRicardo PastorelloTari King ASO Visual Abstract 13 July 2022 Pages: 7737 - 7738
The 21-Gene Recurrence Score in Clinically High-Risk Lobular and Ductal Breast Cancer: A National Cancer Database Study Mary Kathryn AbelAmy M. ShuiRita A. Mukhtar Breast Oncology Open access 09 July 2022 Pages: 7739 - 7747
ASO Author Reflections: Discordant Clinical and Molecular Risk in Invasive Lobular Carcinoma of the Breast: The 21-Gene Recurrence Score in the National Cancer Database by Histologic Subtype Mary Kathryn AbelRita A. Mukhtar ASO Author Reflections Open access 07 July 2022 Pages: 7748 - 7749
ASO Visual Abstract: The 21-Gene Recurrence Score in Clinically High Risk Lobular and Ductal Breast Cancer—A National Cancer Database Study Mary Kathryn AbelAmy M. ShuiRita A. Mukhtar ASO Visual Abstract 07 July 2022 Pages: 7750 - 7750
Individualized Risk Prediction Tool for Serious Wound Complications After Mastectomy With and Without Immediate Reconstruction Katelin B. NickelTerence M. MyckatynCDC Prevention Epicenter Program Breast Oncology 13 July 2022 Pages: 7751 - 7764
ASO Author Reflections: Need for Individualized Risk Prediction to Facilitate Shared Decision Making in Post-mastectomy Breast Reconstruction Margaret A. OlsenTerence M. MyckatynClara N. Lee ASO Author Reflections 13 July 2022 Pages: 7765 - 7766
ASO Visual Abstract: Individualized Risk Prediction Tool for Serious Wound Complications after Mastectomy with and without Immediate Reconstruction Katelin B. NickelTerence M. MyckatynCDC Prevention Epicenter Program ASO Visual Abstract 15 July 2022 Pages: 7767 - 7768
Factors Influencing Non-sentinel Lymph Node Involvement in Patients with Positive Sentinel Lymph Node(s) After Neoadjuvant Chemotherapy for Breast Cancer Stacy B. SandersTanya L. HoskinJudy C. Boughey Breast Oncology 13 July 2022 Pages: 7769 - 7778
ASO Visual Abstract: Factors Influencing Non-Sentinel Lymph Node Involvement in Patients with Positive Sentinel Lymph Node(s) After Neoadjuvant Chemotherapy for Breast Cancer Stacy B. SandersTanya L. HoskinJudy C. Boughey ASO Visual Abstract 25 July 2022 Pages: 7779 - 7779
Correction to : Should We Completely Exclude Locoregional Therapy for the Primary Tumor from Our Clinical Practice in De Novo Metastatic Breast Cancer? Tulay KusGokmen Aktas Correction 22 June 2022 Pages: 7780 - 7780
Multidimensional Immunophenotyping of Intraductal Papillary Mucinous Neoplasms Reveals Novel T Cell and Macrophage Signature Austin M. EckhoffAshley A. FletcherPeter J. Allen Pancreatic Tumors 13 July 2022 Pages: 7781 - 7788
ASO Author Reflections: Spatial Immunophenotyping of Intraductal Papillary Mucinous Neoplasm Austin EckhoffPeter J. Allen ASO Author Reflections 14 July 2022 Pages: 7789 - 7790
ASO Visual Abstract: Multidimensional Immunophenotyping of Intraductal Papillary Mucinous Neoplasms Reveals Novel T Cell and Macrophage Signature Austin M. EckhoffAshley A. FletcherPeter J. Allen ASO Visual Abstract 16 August 2022 Pages: 7791 - 7792
Surgical Approach does not Affect Return to Intended Oncologic Therapy Following Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: A Propensity-Matched Study Samer A. NaffoujeSivesh K. KamarajahFadi S. Dahdaleh Pancreatic Tumors 12 August 2022 Pages: 7793 - 7803
ASO Author Reflections: Minimally Invasive Pancreaticoduodenectomy for Pancreatic Cancer: Are We Maximizing Delivery of Multimodality Therapy? Fadi DahdalehSamer Naffouje ASO Author Reflections 13 August 2022 Pages: 7804 - 7805
ASO Visual Abstract: Surgical Approach does not Affect Return to Intended Oncologic Therapy After Pancreaticoduodenectomy for Pancreatic Adenocarcinoma—A Propensity Score-Matched Study Samer A. NaffoujeSivesh K. KamarajahFadi S. Dahdaleh ASO Visual Abstract 25 August 2022 Pages: 7806 - 7807
Long-Term Outcomes for Patients with Multiple Endocrine Neoplasia Type 1 and Duodenopancreatic Neuroendocrine Neoplasms Jason B. LiuJinman CaiLinwah Yip Pancreatic Tumors 13 August 2022 Pages: 7808 - 7817
ASO Visual Abstract: Long-Term Outcomes of Patients with Multiple Endocrine Neoplasia Type 1 and Duodenopancreatic Neuroendocrine Neoplasms Jason B. LiuJinman CaiLinwah Yip ASO Visual Abstract 15 September 2022 Pages: 7818 - 7819
Correction to: Nationwide Validation of the 8th American Joint Committee on Cancer TNM Staging System and Five Proposed Modifications for Resected Pancreatic Cancer Thijs J. SchoutenLois A. DaamenThe Dutch Pancreatic Cancer Group Correction Open access 07 July 2022 Pages: 7820 - 7821
Primary Tumor Resection is Associated with Improved Disease-Specific Mortality in Patients with Stage IV Small Intestinal Neuroendocrine Tumors (NETs): A Comparison of Upfront Surgical Resection Versus a Watch and Wait Strategy in Two Specialist NET Centers Sonja LevyJames D. ArthurMargot E. T. Tesselaar Endocrine Tumors 16 July 2022 Pages: 7822 - 7832
ASO Visual Abstract: Primary Tumour Resection is Associated with Improved Disease-Specific Mortality in Patients with Stage IV Small Intestinal Neuroendocrine Tumours (NET)—A Comparison of Upfront Surgical Resection versus a Watch-and-Wait Strategy in Two Specialist NET Centres Sonja LevyJames D. ArthurMargot E. T. Tesselaar ASO Visual Abstract 29 July 2022 Pages: 7833 - 7834
Prognosis of Patients with 1–4 cm Papillary Thyroid Cancer Who Underwent Lobectomy: Focus on Gross Extrathyroidal Extension Invading Only the Strap Muscles Ahreum JangMeihua JinWon Gu Kim Endocrine Tumors 30 July 2022 Pages: 7835 - 7842
ASO Visual Abstract: Prognosis of Patients with 1–4-cm Papillary Thyroid Cancer Who Underwent Lobectomy—Focus on Gross Extrathyroidal Extension Invading Only Strap Muscles Ahreum JangMeihua JinWon Gu Kim ASO Visual Abstract 07 September 2022 Pages: 7843 - 7844
Prediction of Implant Size Based on Breast Volume Using Mammography with Fully Automated Measurements and Breast MRI Young Seon KimHyun Geun ChoJoon Seok Lee Reconstructive Oncology 20 June 2022 Pages: 7845 - 7854
ASO Author Reflections: Prediction of Implant Size Based on Breast Volumetry Using Mammography and Breast MRI in DTI Breast Reconstruction Young Seon KimHyun Geun ChoJoon Seok Lee ASO Author Reflections 18 June 2022 Pages: 7855 - 7856
ASO Visual Abstract: Prediction of Implant Size Based on Breast Volume Using Mammography with Fully Automated Measurement and Breast MRI Young Seon KimHyun Geun ChoJoon Seok Lee ASO Visual Abstract 19 July 2022 Pages: 7857 - 7858
New Robotic System with Wristed Microinstruments Allows Precise Reconstructive Microsurgery: Preclinical Study Alberto BallestínGerardo MalzoneMarco Innocenti Reconstructive Oncology 21 June 2022 Pages: 7859 - 7867
Vascularized Lymph Node Transfer Improved Outcomes of Elderly Patients with Secondary Upper Extremity Lymphedema Eamon C. FrancisBong-Sung KimMing-Huei Cheng Reconstructive Oncology 02 July 2022 Pages: 7868 - 7878
ASO Visual Abstract: Vascularized Lymph Node Transfer Improved Outcomes of Elderly Secondary Upper Extremity Lymphedema Eamon C. FrancisBong-Sung KimMing-Huei Cheng ASO Visual Abstract 09 July 2022 Pages: 7879 - 7880
Novel Strategies for Managing Retropharyngeal Lymph Node Metastases in Head and Neck and Thyroid Cancer with Transoral Robotic Surgery (TORS) George GarasNick J. RolandJason C. Fleming Head and Neck Oncology 16 July 2022 Pages: 7881 - 7890
ASO Author Reflections: Novel Treatment De-escalation Strategies for Retropharyngeal Metastatic Disease in Head and Neck and Thyroid Cancer with Transoral Robotic Surgery (TORS) George Garas ASO Author Reflections 26 July 2022 Pages: 7891 - 7892
ASO Visual Abstract: Novel Strategies for Managing Retropharyngeal Lymph Node Metastases in Head and Neck and Thyroid Cancer with TransOral Robotic Surgery (TORS) George GarasNick J. RolandJason C. Fleming ASO Visual Abstract 08 August 2022 Pages: 7893 - 7894
Correction: Trimming of Facial Artery Myomucosal Flap (FAMM) using Indocyanine Green Fluorescence Video-Angiography: Operative Nuances Leone GiordanoMarco FamiliariMario Bussi Correction 02 September 2022 Pages: 7895 - 7895
Prediction of Metachronous Peritoneal Metastases After Radical Surgery for Colon Cancer: A Scoring System Obtained from an International Multicenter Cohort Corrado PedrazzaniGiulia TurriGyu Seog Choi Colorectal Cancer Open access 05 July 2022 Pages: 7896 - 7906
ASO Author Reflections: Toward the Prediction of Peritoneal Recurrence After Curative Resection for Colon Cancer Corrado PedrazzaniGiulia TurriGyu Seog Choi ASO Author Reflections 12 July 2022 Pages: 7907 - 7908
ASO Visual Abstract: Prediction of Metachronous Peritoneal Metastases After Radical Surgery for Colon Cancer: A Scoring System Obtained from an International Multicenter Cohort Corrado PedrazzaniGiulia TurriGyu Seog Choi ASO Visual Abstract 04 September 2022 Pages: 7909 - 7910
Effect of Surgical Humidification on Inflammation and Peritoneal Trauma in Colorectal Cancer Surgery: A Randomized Controlled Trial Shienny SampurnoTimothy ChittleboroughAndrew C. Lynch Colorectal Cancer Open access 06 July 2022 Pages: 7911 - 7920
ASO Visual Abstract: Effect of Surgical Humidification on Inflammation and Peritoneal Trauma in Colorectal Cancer Surgery—A Randomised Controlled Trial Shienny SampurnoTimothy ChittleboroughAndrew C. Lynch ASO Visual Abstract 25 July 2022 Pages: 7921 - 7922
Comments on Superior Mesenteric Artery First Approach for Right Colectomy Jens Marius NesgaardBojan V. StimecDejan Ignjatovic Colorectal Cancer 16 July 2022 Pages: 7923 - 7924
Response to Letter to the Editor: “Comments to Superior Mesenteric Artery First Approach for Right Colectomy” by Jens Marius Nesgaard et al. Wenjun LuoTingting LuYanling Xiao Colorectal Cancer 11 July 2022 Pages: 7925 - 7926
Effect of Socioeconomic Inequalities on the Surgical Treatment and Outcomes of Patients with Colon Cancer Jaiveer SinghAmudhan KannanSudharsanan Sundaramurthi Colorectal Cancer 29 July 2022 Pages: 7927 - 7928
Comment on “Association of Albumin-Bilirubin Grade and Myosteatosis with its Prognostic Significance for Patients with Colorectal Cancer” Min ZouMing-Bin GuiFeng Gao Colorectal Cancer 13 August 2022 Pages: 7929 - 7930
Reply to Letter by Min Zou et al.: Comment on “Association of Albumin–Bilirubin Grade and Myosteatosis with its Prognostic Significance for Patients with Colorectal Cancer” Jeonghyun Kang Colorectal Cancer 06 August 2022 Pages: 7931 - 7932
Comments on “The Impact of Neoadjuvant Chemotherapy on the Surgical Management of Colorectal Peritoneal Metastases: A Systematic Review and Meta-analysis” Gabriel LiberaleMichel MoreauDeborah Repullo Peritoneal Surface Malignancy 13 September 2022 Pages: 7933 - 7934
Reply to Comments on “The Impact of Neoadjuvant Chemotherapy on the Surgical Management of Colorectal Peritoneal Metastases: A Systematic Review and Meta-analysis” Michael P. FloodJoseph C. H. KongAlexander G. Heriot Colorectal Cancer 14 September 2022 Pages: 7935 - 7936
Correction to: Association of RAS/BRAF Status and Prognosis of Metastatic Colorectal Cancer: Analysis of 1002 Consecutive Cases Wentao TangYu LiuJianmin Xu Correction 24 June 2022 Pages: 7937 - 7937